Lara Patel

Lara Patel is an accomplished finance professional with extensive experience in financial planning and analysis. Currently serving as Associate Director of FP&A at Vera Therapeutics, Inc. since October 2022, Lara previously held the position of Financial Planning and Analysis Manager at BridgeBio from June 2021 to September 2022. Prior to that, Lara was a Senior Financial Analyst at MyoKardia from June 2019 until its acquisition by Bristol-Myers Squibb, and also worked as a Financial Analyst-Operations and Sales Operations Analyst at Nevro from February 2017 to June 2019. Lara began the career as a Financial Analyst at Arista Networks from June 2015 to February 2016. Lara holds an MBA in Finance from California State University, Fullerton, and a Chartered Accountant designation in Auditing & Finance from The Institute of Chartered Accountants of India.